Preventicus specializes in creating solutions for the prevention of stroke, by using smartphones and other smart devices to detect irregular heartbeats, particularly atrial fibrillation.

Our core technology turns smartphones and smart watches into mobile EKG machines, with no additional hardware needed. With Preventicus installed, a mobile device becomes a personal bodyguard, at the ready in a pocket or handbag — and certified and proven in clinical tests.

Initial investment:

B2G Partner:
Thomas R. Villinger



Founding of the company, seed financing round
Certification as a producer of medical products in accordance with ISO 13485
Launch of our core technology, “Preventicus Heartbeats,” as a CE-certified digital medical product for the detection of atrial fibrillation using only a smart phone. Results of the first clinical trial show that our product is 95 percent accurate. The first health insurance companies begin using our solutions.
Other B2B solutions are launched (telecare services, integrated prevention programs). By the end of 2017, our application has been installed on 170,000 smart phones, and thus about 2.3 million heart-rhythm analyses in all have been carried out, which amounts to about 2,000 per day. The first major contract with an insurer is signed, with a value of over 500,000 euros.

“The BORN2GROW fund has made a tremendous contribution to our company, by supporting us from the seed phase onward, and working together with us to complete a very successful series A financing round. I would like to especially thank Mr. Steffen, who was there right from the start, and also Mr. Villinger. Without their commitment and faith in us, none of this would have been possible.”

Dr. Thomas Hübner
Founder and CEO